Pregnant Women with Atrial Septal Defect (ASD) - Pulmonary Hypertension (PH): Management ASD - PH in Pregnancy

Arif Wicaksono, Heny Martini, Ardian Rizal, Anna Fuji Rahimah



Pulmonary Hypertension (PH) is a condition where there is an increase in Pulmonary Vascular Resistance (PVR) and an increase in the mean Pulmonary Arterial Pressure (mPAP) to more than 20 mmHg. PH can occur in someone with Congenital Heart Disease (CHD). PH conditions can aggravate pregnancy in women with CHD. So that women with PH are recommended not to undergo pregnancy. However, it is possible for women with CHD with PH conditions to undergo pregnancy. In these conditions, optimizing PH therapy is important so that pregnant women with PH do not experience a worsening of the condition and can carry out their pregnancy well until delivery.


Case Presentations:

A 38-year-old female patient with a history of Atrial Septal Defect-Pulmonary Hypertension came for routine control to the cardiac clinic with the condition of pregnancy of her 4th child who was just discovered when she was 6 months pregnant. Since giving birth to her third child, the patient began to complain of being easily tired when doing activities accompanied by swollen legs that disappeared with rest. At that time, the patient went to a cardiologist for an echocardiography examination and was diagnosed as Atrial Septal Defect (ASD)-Pulmonary Hypertension (PH). Since then, the patient has been routinely treated at a cardiologist with Pulmonary Hypertension drugs, including Phospodiesterase5 (PDE5) inhibitors (Sildenafil) and Prostacyclin Analogue (Dorner). The patient had done Transesophageal Echocardiography (TEE) with the results of ASD secundum suitable for closure by device. Patients with Right Heart Catheterization (RHC) results, ASD secundum with PH High Flow High Resistance reactive to Vasoreactivity Test. Since the patient was found to be pregnant, the patient continued to use Sildenafil and discontinued the use of Dorner. The patient then continued treatment in a multidisciplinary team.


Conclusion :

Management of pregnant women with CHD and PH is important because the condition of PH itself further aggravates the condition of pregnancy. Medical management for PH in pregnant women follows the guidelines for the safety of drugs in pregnancy. So that the choice of therapy is crucial related to the goal of treatment to control the PH condition in the patient but still pay attention to safety in pregnancy conditions.


Congenital Heart Disease, Pulmonary Hypertension, Phospodiesterase-5 (PDE-5)-Inhibitor, Prostacyclin Analogue

Full Text:



Martin SR, Edwards A. Pulmonary Hypertension and Pregnancy. Obstetrics and Gynecology 2019;134(5):974–87. 10.1097/AOG.0000000000003549

E.A. Orchard, N. Wilson, O.J.M. Ormerod. Device closure of atrial septal defect during pregnancy for recurrent cerebrovascular accidents. INTERNATIONAL JOURNAL OF CARDIOLOGY 2009;241–2.

Stokes MB, Xu B, Nerlekar N, Lockwood SM, Harper RW. Successful percutaneous closure of an extremely large secundum atrial septal defect during pregnancy. Cardiovasc Diagn Ther 2017;7(3):336–9. 10.21037/cdt.2016.10.03

Pieper PG, Hoendermis ES. Pregnancy in women with pulmonary hypertension. Netherlands Heart Journal 2011;19(12):504–8. 10.1007/s12471-011-0219-9

Sakurako Mishima, Takashi Mitsui, Satoshi Akagi, Tomohiro Mitoma. Pregnant Woman With Severe Pulmonary Hypertension Due to an Atrial Septal Defect That Was Triggered by Pregnancy. Res Sq 2022;

Luthra A, Bajaj R, Jafra A, Jangra K, Arya VK. Anesthesia in pregnancy with heart disease. Saudi J Anaesth. 2017;11(4):454–71. 10.4103/sja.SJA_277_17

Fernandes SM, Arendt KW, Landzberg MJ, Economy KE, Khairy P. Pregnant women with congenital heart disease: Cardiac, anesthetic and obstetrical implications. Expert Rev Cardiovasc Ther. 2010;8(3):439–48. 10.1586/erc.09.179

Huang S, DeSantis ERH. Treatment of pulmonary arterial hypertension in pregnancy. American Journal of Health-System Pharmacy. 2007;64(18):1922–6. 10.2146/ajhp060391

RA Curry, C Fletcher, E Gelson, MA Gatzoulis, M Woolnough. Pulmonary hypertension and pregnancy—a review of 12 pregnancies in nine women. An International Journal of Obstetric and Gynaecology 2012;

Afify H, Kong A, Bernal J, Elgendy IY. Pulmonary Hypertension in Pregnancy: Challenges and Solutions. Integr Blood Press Control. 2022;15:33–41. 10.2147/IBPC.S242242

Dunn L, Greer R, Flenady V, Kumar S. Sildenafil in Pregnancy: A Systematic Review of Maternal Tolerance and Obstetric and Perinatal Outcomes. Fetal Diagn Ther. 2017;41(2):81–8. 10.1159/000453062

Madden BP. Pulmonary hypertension and pregnancy. Int J Obstet Anesth. 2009;18(2):156–64. 10.1016/j.ijoa.2008.10.006



  • There are currently no refbacks.

Copyright (c) 2024 Arif Wicaksono, Heny Martini, Ardian Rizal, Anna Fuji Rahimah

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.